International journal of nanomedicine

Selenium Nanoparticle-Enhanced Lactobacillus casei May Prevent Memory Problems in Mice by Changing Gut Bacteria and Brain Communication

Updated

Abstract

Thirteen weeks of treatment with ATCC 393-SeNPs significantly improved cognitive dysfunction in mice with Alzheimer's disease.

  • ATCC 393-SeNPs reduced amyloid beta aggregation and hyperphosphorylation of TAU protein, which are associated with Alzheimer's disease.
  • The treatment prevented neuronal death by affecting key signaling pathways related to brain health.
  • ATCC 393-SeNPs improved intestinal barrier function and increased antioxidant capacity compared to standard ATCC 393.
  • The intervention restored gut microbiota balance and boosted levels of short-chain fatty acids and neurotransmitters.
  • ATCC 393-SeNPs inhibited microglial activation and provided protection against oxidative stress and neuroinflammation.

Simplified

Key numbers

13 weeks
Cognitive Improvement
Duration of ATCC 393 or ATCC 393-SeNPs treatment in AD model mice.
0.3 mg/kg
Reduction in Aβ Aggregation
Selenium content in the ATCC 393-SeNPs diet administered to mice.

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

The authors report no conflicts of interest in this work.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free